Vanguard Portfolio Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
ICM
Vanguard Portfolio Management's CNMD Position: Q2 2026 in Review
Vanguard Portfolio Management increased its CONMED (CNMD) stake by 5.4% in Q2 2026, buying an estimated $4.04M and bringing the position to 2,188,761 shares worth $71.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1617.
Vanguard Portfolio Management first reported a position in CNMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $73.4M in Q1 2026. 244 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Vanguard Portfolio Management held 2,188,761 shares of CONMED worth $71.6M as of Q2 2026.
- Vanguard Portfolio Management bought 112,344 CONMED shares in Q2 2026, an estimated $4.04M.
- CONMED made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1617 holding.
- Vanguard Portfolio Management first reported a position in CONMED in Q1 2026 and has held it in 2 quarters since.
- Vanguard Portfolio Management's CONMED position peaked at $73.4M in Q1 2026.
- 244 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.